The reported statements, read against the company's own industry.
The statements on file don't all cover the same year: income statement FY2024, balance sheet FY2025, cash-flow statement FY2024. Each figure below is labelled with the year it comes from.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
13.03BCNY
1.95B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
76.33x
vs Conglomerates peers
Updated Oct 22, 2026
Revenue (TTM)
2.44BCNY
365.98M · vs all stocks (USD)
Updated Oct 22, 2026
Profit Margin
6.78%
vs Conglomerates peers
Updated Oct 22, 2026
Beta
0.7920x
vs all stocks
Updated Oct 22, 2026
52-Week Change
-6.01%
vs all stocks
Updated Oct 22, 2026
Market Capitalization
13.03BCNY
1.95B · vs all stocks (USD)
Updated Oct 22, 2026
Enterprise Value
14.52BCNY
2.18B · vs all stocks (USD)
Updated Oct 22, 2026
Trailing P/E
76.33x
vs Conglomerates peers
Updated Oct 22, 2026
Price to Sales (TTM)
5.58x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 5.34×.Updated Oct 22, 2026
Price to Book (MRQ)
3.65x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to Revenue
5.95x
vs Conglomerates peers
Updated Oct 22, 2026
Enterprise to EBITDA
189.16x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 48.53×.Updated Oct 22, 2026
Gross Margin
10.20%
vs Conglomerates peers
Updated Oct 22, 2026
Profit Margin
6.78%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Margin
2.85%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Assets (TTM)
-0.60%
vs Conglomerates peers
Updated Oct 22, 2026
Return on Equity (TTM)
4.55%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue (TTM)
2.44BCNY
365.98M · vs all stocks (USD)
Updated Oct 22, 2026
Revenue per Share (TTM)
0.8690CNYUpdated Oct 22, 2026
Quarterly Revenue Growth
63.70%
vs Conglomerates peers
Updated Oct 22, 2026
Gross Profit (TTM)
207.45MCNY
31.09M · vs all stocks (USD)
Updated Oct 22, 2026
EBITDA (TTM)
299.13MCNY
44.84M · vs all stocks (USD)
Updated Oct 22, 2026
Net Income (TTM)
165.59MCNY
24.82M · vs all stocks (USD)
Updated Oct 22, 2026
Quarterly Earnings Growth (YoY)
-65.20%
vs Conglomerates peers
Updated Oct 22, 2026
Operating Cash Flow (TTM)
-309.29MCNY
-46.36M · vs all stocks (USD)
Updated Oct 22, 2026
Levered Free Cash Flow (TTM)
-99.60MCNY
-14.93M · vs all stocks (USD)
Updated Oct 22, 2026
5-Year Average Dividend Yield
0.61%
vs all stocks
Updated Oct 22, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Oct 22, 2026
Revenue
1.33BCNYFY2024 · Dec 31, 2024
Cost of Goods Sold
1.17BCNYFY2024 · Dec 31, 2024
Gross Profit
159.78MCNYFY2024 · Dec 31, 2024
Operating Income
40.60MCNY
6.09M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Pre-tax Income
207.74MCNYFY2024 · Dec 31, 2024
Income Tax Expense
42.18MCNYFY2024 · Dec 31, 2024
Net Income
165.55MCNYFY2024 · Dec 31, 2024
EBIT
230.72MCNYFY2024 · Dec 31, 2024
EBITDA (Income Statement)
382.75MCNYFY2024 · Dec 31, 2024
Research & Development
40.76MCNYFY2024 · Dec 31, 2024
Selling, General & Administrative
37.05MCNYFY2024 · Dec 31, 2024
Other Operating Expenses
11.53MCNYFY2024 · Dec 31, 2024
Non-operating Interest Income
8.27MCNYFY2024 · Dec 31, 2024
Non-operating Interest Expense
22.99MCNYFY2024 · Dec 31, 2024
EPS (Basic)
0.0600CNYFY2024 · Dec 31, 2024
EPS (Diluted)
0.0600CNYFY2024 · Dec 31, 2024
Basic Shares Outstanding
3.16BSharesFY2024 · Dec 31, 2024
Diluted Shares Outstanding
3.16BSharesFY2024 · Dec 31, 2024
Net Income from Continuing Operations
165.55MCNYFY2024 · Dec 31, 2024
Minority Interests (P&L)
23.90MCNYFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00CNYFY2024 · Dec 31, 2024
Operating Cash Flow
-95.52MCNYFY2024 · Dec 31, 2024
Free Cash Flow
-195.75MCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
633.20MCNYFY2024 · Dec 31, 2024
Starting Profit (CF Statement)
165.55MCNYFY2024 · Dec 31, 2024
Other Non-cash Items
18.66MCNYFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-203.41MCNYFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-76.33MCNYFY2024 · Dec 31, 2024
Capital Expenditures
-100.23MCNYFY2024 · Dec 31, 2024
Net Acquisitions
8.20MCNYFY2024 · Dec 31, 2024
Purchase of Investments
-466.23MCNYFY2024 · Dec 31, 2024
Sale of Investments
456.81MCNYFY2024 · Dec 31, 2024
Other Investing Activity
7.71MCNYFY2024 · Dec 31, 2024
Net Investing Cash Flow
-93.74MCNYFY2024 · Dec 31, 2024
Long-term Debt Issuance
159.70MCNYFY2024 · Dec 31, 2024
Long-term Debt Payments
-61.78MCNYFY2024 · Dec 31, 2024
Common Dividends Paid
-13.28MCNYFY2024 · Dec 31, 2024
Other Financing Charges
-46.49MCNYFY2024 · Dec 31, 2024
Net Financing Cash Flow
38.15MCNYFY2024 · Dec 31, 2024
Shares Outstanding
2.97BSharesUpdated Oct 22, 2026
Float Shares
1.72BSharesUpdated Oct 22, 2026
% Held by Insiders
43.24%
vs all stocks
Updated Oct 22, 2026
% Held by Institutions
1.05%
vs all stocks
Updated Oct 22, 2026
Total Cash (MRQ)
661.22MCNY
99.11M · vs all stocks (USD)
Updated Oct 22, 2026
Total Cash per Share (MRQ)
0.2220CNYUpdated Oct 22, 2026
Total Debt (MRQ)
1.55BCNY
233.01M · vs all stocks (USD)
Updated Oct 22, 2026
Total Debt to Equity (MRQ)
0.4168x
vs Conglomerates peers
Updated Oct 22, 2026
Current Ratio (MRQ)
1.16x
vs Conglomerates peers
Updated Oct 22, 2026
Book Value per Share (MRQ)
1.25CNYUpdated Oct 22, 2026
Cash Equivalents
295.16MCNYFY2025 · Dec 31, 2025
52-Week Low
3.96CNYUpdated Oct 22, 2026
52-Week High
11.99CNYUpdated Oct 22, 2026
52-Week Change
-6.01%
vs all stocks
Updated Oct 22, 2026
Beta
0.7920x
vs all stocks
Updated Oct 22, 2026
50-Day MA
5.66CNYUpdated Oct 22, 2026
200-Day MA
6.09CNYUpdated Oct 22, 2026
Avg 10-Day Volume
65.80MSharesUpdated Oct 22, 2026
Avg 30-Day Volume
75.65MSharesUpdated Oct 22, 2026
Diluted EPS (TTM)
0.0600CNYUpdated Oct 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.